President-elect Trump announced on Sunday that he has picked Brendan Carr to serve as Chairman of the Federal Communications Commission (FCC) starting in January. Carr, who is currently the senior Republican member of the FCC, was first nominated to the commission by Trump in 2017. In a statement released on Sunday night, Trump commended Carr and noted that he had ...
A new report revealed Vice President Kamala Harris’ presidential campaign paid more than double what was previously reported for the Oprah Winfrey town hall event. FEC filings, first reported by the Washington Examiner, show the Harris campaign made two $500,000 payments to Winfrey’s Harpo Productions on Oct. 15, a month after Winfrey’s town hall with Harris and weeks before the pair ...
Ben Carson broke his silence around rumors of him joining the second Trump administration as the U.S. surgeon general on Sunday, but noted that he plans to speak with President-elect Donald Trump soon. Carson, who served as the secretary of Housing and Urban Development (HUD) from 2017 to 2021 during the first Trump administration, dispelled the false reports in an ...
Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health Innovation Frontier Forum on 18th November 2024. This event will showcase the intersection between technology, health and community. *To view the presentation, please visit: https://abnnewswire.net/lnk/91TD2JM9 About BPH Energy Limited: BPH Energy Limited (ASX:BPH) is an Australian Securities Exchange listed company ...
Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for the development of a unique commercial REO manufacturing facility in Belfast, UK, following the successful completion of a Feasibility Study that demonstrates both strong financial returns and environmental sustainability. The study positions Ionic Technologies as the ‘first mover’ in the development ...
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that a clinical study featuring 68Ga-Trivehexin (68Ga-RAD 301), conducted by Dr. Rehm and colleagues from the Technische Universität Dresden, has now been published in Frontiers in Nuclear Medicine. Clinical study of 44 ...
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting the company’s achievements while waiting for the completion of its listing on the NASDAQ expected at the end of 2024. Canevari provided some updates about the joint venture with MD Anderson Cancer Center and the progress with ...
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101 Phase 2a/b clinical trial in dengue fever. All key data samples have been collected following dosing of all subjects in the Phase 2a (prophylactic) trial as part of Island’s ISLA-101 Phase 2a/b PROTECT clinical trial in dengue fever ...
Lightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at the Company’s recently acquired Esperança project. The discovery supports the Company’s approach to exploration in the district and its positive assessment of the prospectivity within the Lithium Valley region Minas Gerais, Brazil. The discovery has been made during early-stage exploration ...
Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for the full ASX Release This post appeared first on investingnews.com ...